In 2009, Milner et al., reported that the adipokine fatty acid-binding protein 4 (FABP4) was elevated in NAFLD patients without HCC versus healthy controls, distinguishing steatohepatitis from simple steatosis and predicting liver inflammation and fibrosis [140]. Here, FABP4 is linked to hepatocellular carcinoma.